Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acetylon pharmaceuticals
alder biopharmaceutical
allergan
ambys medicines
american academy of neurology
amgen
atogepant
battlefield
bio
biohaven
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cell therapy
clinical trials
constellation pharmaceuticals
deals
detroit blog main
detroit top stories
disrupt
disrupt sf 2018
drugs
eli lilly
eptinezumab
erenumab
What
make
3
×
new
3
×
big
medicines
affordable
aiming
ambys
amounts
approval
arguments
benefits
biotech
cannabinoids
cb
class
commercialized
companies
competitors
control
cultivation
deadly
deal
debuted
decades
diseases
drug
drugs
established
fda
formed
future
ground
grown
inside
intensive
lab
launch
legal
liver
marijuana
Language
Current search:
new
×
make
×
biotech
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@techcrunch.com
5 years ago
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
